Literature DB >> 1908141

Stimulation of tissue-type plasminogen activator synthesis by retinoids in cultured human endothelial cells and rat tissues in vivo.

T Kooistra1, J P Opdenberg, K Toet, H F Hendriks, R M van den Hoogen, J J Emeis.   

Abstract

Tissue-type plasminogen activator (t-PA) and its inhibitor, plasminogen activator inhibitor 1 (PAI-1), play an important role in regulating the fibrinolytic capacity of plasma. Both t-PA and PAI-1 are synthesized by the endothelium. We report that retinoic acid (vitamin A acid) and other retinoids rather specifically stimulate the production of t-PA by cultured human umbilical vein endothelial cells. Effective retinoids induced a dose-dependent (range: 0.01-50 microM) increase in the production of t-PA of maximally about six-fold, while simultaneously causing no or only a small increase (less than two-fold) of PAI-1. The effects on t-PA synthesis were apparent by 4-8 h, and reached maximal values after about 24-48 h of incubation with retinoid. The retinoid effect on t-PA production was accompanied by increased t-PA mRNA levels, without any parallel change in PAI-1 or GAPDH mRNA concentrations. The study also shows that modifications at the carboxyl group of retinoic acid are associated with a decrease in stimulatory potency. The stimulatory pathway appears to be identical for all retinoids but distinct from a pathway by which another strong inducer, sodium butyrate, induces t-PA synthesis in endothelial cells. The induction of t-PA by retinoids might involve protein kinase C (PKC) as judged by an experiment using a specific PKC inhibitor. The effect of retinoids on the fibrinolytic system in vivo was assessed by feeding rats with a vitamin A deficient diet or a diet with excess of vitamin A or other retinoids.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1908141

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  7 in total

Review 1.  Permeable endothelium and the interstitial space of brain.

Authors:  M W Brightman; M Kaya
Journal:  Cell Mol Neurobiol       Date:  2000-04       Impact factor: 5.046

2.  All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications.

Authors:  G L Defer; H Adle-Biassette; F Ricolfi; L Martin; F J Authier; C Chomienne; L Degos; J D Degos
Journal:  J Neurooncol       Date:  1997-09       Impact factor: 4.130

3.  Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-kappaB.

Authors:  C B Louise; M C Tran; T G Obrig
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

4.  Stimulation of tissue plasminogen activator production by retinoic acid: synergistic effect on protein kinase C-mediated activation.

Authors:  R D Medh; L Santell; E G Levin
Journal:  Blood       Date:  1992-08-15       Impact factor: 22.113

5.  Experimental models of endocrine responsive breast cancer: strengths, limitations, and use.

Authors:  Robert Clarke; Brandon C Jones; Catherine M Sevigny; Leena A Hilakivi-Clarke; Surojeet Sengupta
Journal:  Cancer Drug Resist       Date:  2021-07-08

6.  Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.

Authors:  S Kojima; K Nara; D B Rifkin
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

Review 7.  Improvement of Psychotic Symptoms and the Role of Tissue Plasminogen Activator.

Authors:  Silvia Hoirisch-Clapauch; Antonio E Nardi
Journal:  Int J Mol Sci       Date:  2015-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.